Deloitte ranked #1 worldwide, based on revenue, in Life Sciences Consulting by Kennedy
New York, 13 February 2013 – Deloitte Touche Tohmatsu Limited (DTTL) is pleased to announce that Deloitte has been ranked number one in Life Sciences by Kennedy based on revenue, in their report Consulting to the Life Sciences Sector, 2012.
The report is the first in the series and covers the fastest-growing healthcare sector, life sciences, with analysis aligned to consulting needs across the four subsectors: pharmaceutical, biotechnology, medical device, and drug distribution.
According to the report, Deloitte’s post-transaction services, regulatory and risk expertise and commercial operating models are strengths. Kennedy notes that “Deloitte provides one of the widest ranges of capability in the industry and the relationship models to support large program initiatives. The breadth of these capabilities and the organizational ability to integrate these skills together allow Deloitte to focus on a variety of strategic issues such as pricing and profitability, strategic commercial models, and partnering models for R&D.”
“Deloitte is honored that Kennedy has acknowledged the capabilities of our member firms around the world in serving clients in the life sciences and health care industry,” says Pete Mooney, Global Life Sciences and Health Care (LSHC) industry group leader, DTTL. “Kennedy’s recognition speaks to the breadth and depth of Deloitte’s capabilities, our strong global footprint, and our ability to team across borders and service areas. These accomplishments are a significant source of pride for our industry group.”
Additional findings from the report:
- Deloitte continues to be the world’s largest life sciences consultancy, based on revenue
- “LS Post-transaction service - Deloitte’s breadth of skills positions [Deloitte]to provide a wide range of services following a financial transaction. Key areas of focus include, finance, IT HR and product line alignment, organization re-alignment, tax advisory, and enterprise risk.”
- “LS Regulatory and Risk – [Deloitte] Provides a wide range of strategic, financial, operational and regulatory compliance risk services"
- “LS Commercial Operating Models – [Deloitte] Conducts a wide range of work in support of pricing, profitability, go-to-market strategies, and local sales and marketing alignment”
Source: Kennedy Consulting Research & Advisory; Consulting to the Life Sciences Sector, 2012; © 2013 Kennedy Information, LLC. Reproduced under license
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms.
Deloitte provides audit, tax, consulting, and financial advisory services to public and private clients spanning multiple industries. With a globally connected network of member firms in more than 150 countries, Deloitte brings world-class capabilities and high-quality service to clients, delivering the insights they need to address their most complex business challenges. Deloitte has in the region of 200,000 professionals, all committed to becoming the standard of excellence.